- Push-out Score determined
- After 10 years in the position
- Accolades, praise, thanks and good wishes for Arduini
- Search for a successor
- Arduini said 110 words
(exechange) — Princeton, New Jersey, June 24, 2021 — Pete Arduini, chief executive of Integra, leaves. As announced by Integra LifeSciences Holdings Corp. in a news release and in a regulatory filing published on Thursday, June 24, 2021, Peter J. (Pete) Arduini leaves his post as chief executive officer at the medical technology company after 10 years in the role, effective December 31, 2021.
Integra will undertake a search for a successor.
Arduini will be President and Chief Executive Officer at GE Healthcare
“Peter Arduini will step down as Chief Executive Officer at the end of 2021 to accept the role of President and Chief Executive Officer of GE Healthcare,” Integra said.
GE Healthcare is a subsidiary of multinational conglomerate General Electric. The company is a manufacturer of diagnostic imaging agents and radiopharmaceuticals for imaging modalities that are used in medical imaging procedures.
Integra said: “On June 22, 2021, Peter J. Arduini informed Integra LifeSciences Holdings Corporation (the “Company”) of his intention to resign from his position as President and Chief Executive Officer and director of the Company in order to accept an executive position with another company. Mr. Arduini’s resignation will be effective December 31, 2021.”
Share price increase since June 2016
The announcement follows an increase in Integra LifeSciences Holdings Corp.’s share price of 87% since June 2016.
Chaired by Stuart Essig
Stuart Essig serves as Integra LifeSciences Holdings Corp.’s Chairman.
Esssig is Integra’s Chairman of the Board of Directors. He has been the Company’s Chairman since January 2012 and a director since he joined Integra in 1997.
In the position of CEO since 2012
Pete Arduini became CEO of the Company in 2012.
Pete Arduini is Integra’s President and Chief Executive Officer and a director.
He joined Integra in November 2010 as President and Chief Operating Officer and was appointed Chief Executive Officer and a director in January 2012.
Before joining Integra, Arduini was corporate vice president and president of Medication Delivery, Baxter Healthcare, from 2005 to 2010.
Arduini was responsible for a $4.8 billion global division of Baxter focused on inpatient pharmaceuticals and devices.
Prior to that, he worked for 15 years in a variety of management roles for domestic and global business for General Electric Healthcare, culminating in leading the global functional imaging business.
Arduini currently serves on the board of directors of Bristol-Myers Squibb Company, where he is a member of the audit committee and the compensation and management development committee.
He serves on the board of directors of ADVAMED, the Advanced Medical Technology Association, the Medical Device Innovation Consortium, and the National Italian American Foundation.
He also serves on the board of trustees of Susquehanna University.
Arduini received his bachelor’s degree in marketing from Susquehanna University and a master’s in management from Northwestern University’s Kellogg School of Management.
Push-out Score determined
The Push-out Score™ determined by exechange gauges the pressure surrounding Pete Arduini’s move on a scale of 0 to 10.
exechange reached out to Integra and offered the company the opportunity to comment on the score.
Read the full story in the exechange report 26.2021 ($).